Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001753926-25-000222
Filing Date
2025-02-11
Accepted
2025-02-11 18:10:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 14474
  Complete submission text file 0001753926-25-000222.txt   16371
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Subject) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87552 | Film No.: 25611256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 140 BROADWAY 38TH FLOOR NEW YORK NY 10005
Business Address 874 WALKER ROAD SUITE C DOVER DE 19904 (646) 845-0040
3i, LP (Filed by) CIK: 0001841619 (see all company filings)

EIN.: 843800874 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A